首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1
【24h】

Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1

机译:合成糖蛋白缀合物在小鼠中引起的血清IgG脂多糖抗体水平高于痢疾志贺氏菌1型的O特异性多糖

获取原文
获取原文并翻译 | 示例
           

摘要

Our development of vaccines to prevent shig- ellosis is based on the hypothesis that a critical (protective) level of serum IgG to the O-specific polysaccharide (O-SP) domain of Shigella lipopolysaccharide (LPS) confers immu- nity. The O-SP is a hapten and must be conjugated to a protein to induce serum antibodies. The O-SP of Shigella dysenteriae type 1 (approx=27 tetrasaccharide repeat units), prepared by acid hydrnlysis of the LPS, was bound to human serum albumin (HSA) by multiple point attachment (O-SP-HSA): The molar ratio of HSA to O-SP was 1.0. Synthetic saccharides, composed of one or multiples of the O-SP tetrasaccharide, equipped with a spacer at their reducing end, were bound to HSA by a single point attachment: The average molar ratios of the saccharides to HSA ranged from 4 to 24. Serum IgG anti-LPS, elicited in mice by O-SP-HSA or synthetic tetra-, octa-, dodeca-, and hexadecasaccharide fragments, was measured by ELISA. Out- bred 6-week.old female mice were injected s.c. three times at biweekly intervals with 2.5 #mu#g or saccharide as a conjugate and were bled 7 days after the second and third injections. Excepting the tetramer, conjugates of the octamer, dodecamer and hexadecamer elicited IgG LPS antibodies after the second injection, a statistically significant rise (booster) after the third injection, and higher levels than those vaccinated with O-SP-HSA (P = 0.0001). The highest geometric mean levels of IgG anti-LPS were elicited by the hexadecamer with 9 chains or 9 moles of saccharide/HSA (15.5 ELISA units) followed by the octamer with 20 chains (11.1
机译:我们开发预防志贺氏菌病的疫苗是基于以下假设:血清志贺氏菌脂多糖(LPS)的O特异性多糖(O-SP)结构域的关键IgG水平具有保护性。 O-SP是半抗原,必须与蛋白质偶联才能诱导血清抗体。通过LPS酸水解制备的痢疾志贺氏菌1型的O-SP(约27个四糖重复单元)通过多点附着(O-SP-HSA)与人血清白蛋白(HSA)结合:摩尔比HSA与O-SP的比值为1.0。由一个或多个O-SP四糖组成的合成糖,在其还原末端配有间隔基,通过单点连接与HSA结合:糖与HSA的平均摩尔比为4至24。血清通过ELISA测定了由O-SP-HSA或合成的四糖,八糖,十二糖和十六糖片段在小鼠中引起的IgG抗LPS。将离体的6周龄雌性小鼠皮下注射。每两周间隔两次,每次2.5μμg或糖作为缀合物,并在第二次和第三次注射后7天放血。除四聚体外,在第二次注射后,八聚物,十二肽和十六胺的缀合物引发IgG LPS抗体,第三次注射后具有统计学上的显着升高(增强),且水平高于接种O-SP-HSA的疫苗(P = 0.0001) 。 IgG抗-LPS的最高几何平均水平是由具有9条链或9摩尔糖/ HSA(15.5 ELISA单位)的六聚体所致,其次是具有20条链的八聚体(11.1)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号